483 Intas Pharmaceuticals May 2017

483 Intas Pharmaceuticals May 2017

Patric Klotzbuecher FDA, Bijoy Panicker FDA, Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Moraiya, India facility and issued inspectional observations (via FDA 483) on 10 May 2017.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 10 May 2017
  • Location: Moraiya, India